Novo Nordisk Financial Overview
Novo Nordisk's market cap is currently $215.69B. The company's EPS TTM is $0.692; its P/E ratio is 13.99; and it has a dividend yield of 3.84%. Novo Nordisk is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $0.92. See an overview of income statement, balance sheet, and cash flow financials.
